Search results
Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March
Reuters via Yahoo Finance· 7 months agoJefferies analyst Michael Yee said the Leqembi patient target given by Eisai was "very achievable"...
10 clinical trials to watch in the first half of 2024
BioPharma Dive via Yahoo Finance· 6 months agoTwo years into a drawn-out downturn, the biotechnology sector finally got news that might buoy its...
10 Best Biotech Stocks Under $10
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we will look at the 10 best biotech stocks under $10. If you want to explore similar biotech stocks with promising prospects that you...
Moderna forecasts COVID sales decline as costs rise, shares fall
Reuters via Yahoo Finance· 1 year agoModerna Inc on Thursday forecast declining COVID-19 vaccine sales and rising costs for 2023, raising...
Q4 2023 Fate Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Edward Dulac; Chief Financial Officer; Fate Therapeutics Inc Michael Yee; Analyst; Jefferies Yigal Nochomovitz; Analyst; Citi Tara Bancroft; Analyst; TD Cowen Tazeen Ahmad; Analyst ...
Eli Lilly Alzheimer's drug setback extends rival Biogen's lead
Reuters via Yahoo News· 1 year agoThe U.S. Food and Drug Administration (FDA) declined to approve donanemab's application because...
Amgen quarterly profit rises 15%, obesity drug trials are on track
Reuters via Yahoo Finance· 4 months ago(Reuters) -Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20%...
Moderna jumps as vaccine shows benefit in head and neck cancer in early study
Reuters via Yahoo News· 2 months agoThe vaccine, designed to train the immune system of patients to recognize and attack specific...
Q1 2024 Schrodinger Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 months agoParticipants Jaren Madden; Senior Vice President, Investor Relations & Corporate Communications; Schrodinger Inc Ramy Farid; President, Chief Executive Officer, Director; Schrodinger Inc Geoffrey ...
ALS drug from Denali, Sanofi falls short in mid-stage study
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: An experimental drug being developed by Denali Therapeutics and partner Sanofi for ALS...
